Related Experiment Video
Updated: Dec 18, 2025

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental
Kellen Hirsch1,2, Elizabeth Taglauer3, Gregory Seedorf1,4,5
1Pediatric Heart Lung Center and.
Insights
Antenatal inflammation increases bronchopulmonary dysplasia risk. Prolyl-hydroxylase inhibitor (PHi) therapy given before birth improved lung development and prevented pulmonary hypertension in a rat model.
Area of Science:
- Neonatal Medicine
- Pulmonary Medicine
- Developmental Biology
Background:
- Antenatal inflammation and placental dysfunction are linked to high bronchopulmonary dysplasia (BPD) risk in preterm infants.
- The role of hypoxia-inducible factor (HIF) augmentation in preventing lung injury from intrauterine inflammation is debated.
Purpose of the Study:
- To investigate if antenatal or postnatal prolyl-hydroxylase inhibitor (PHi) therapy can enhance lung HIF expression, preserve lung growth and function, and prevent pulmonary hypertension.
- To evaluate PHi efficacy in a rat model of chorioamnionitis-induced BPD.
Main Methods:
- Intrauterine endotoxin (ETX) administration to induce inflammation in pregnant rats.
- Administration of PHi drugs (dimethyloxalylglycine or GSK360A) antenatally or postnatally.
- Assessment of lung structure, function, vascularity, and right ventricle hypertrophy (RVH) in offspring.
Main Results:
- Antenatal PHi therapy preserved lung alveolar and vascular growth and lung function.
- PHi treatment prevented RVH and upregulated HIF-1a, HIF-2a, VEGF, and eNOS expression in the lungs.
- Placental structure was also improved by antenatal PHi therapy.
Conclusions:
- Hypoxia-inducible factor (HIF) augmentation via PHi therapy improves lung structure and function and prevents RVH after antenatal inflammation.
- Antenatal PHi therapy shows promise for preventing BPD in infants exposed to intrauterine inflammation.
- Further research into antenatal or postnatal PHi therapy is warranted for BPD prevention strategies.
Abstract:
Rationale: Antenatal inflammation with placental dysfunction is strongly associated with high bronchopulmonary dysplasia (BPD) risk in preterm infants. Whether antenatal or postnatal HIF (hypoxia-inducible factor) augmentation can preserve lung structure and function and prevent pulmonary hypertension after intrauterine inflammation is controversial.Objectives: To determine whether antenatal or postnatal prolyl-hydroxylase inhibitor (PHi) therapy increases lung HIF expression, preserves lung growth and function, and prevents pulmonary hypertension in a rat model of chorioamnionitis-induced BPD caused by antenatal inflammation.Methods: Endotoxin (ETX) was administered to pregnant rats by intraamniotic injection at Embryonic Day 20, and pups were delivered by cesarean section at Embryonic Day 22. Selective PHi drugs, dimethyloxalylglycine or GSK360A, were administered into the amniotic space at Embryonic Day 20 or after birth by intraperitoneal injection for 2 weeks. Placentas and lung tissue were collected at birth for morphometric and Western blot measurements of HIF-1a, HIF-2a, VEGF (vascular endothelial growth factor), and eNOS (endothelial nitric oxide synthase) protein contents. At Day 14, lung function was assessed, and tissues were harvested to determine alveolarization by radial alveolar counts, pulmonary vessel density, and right ventricle hypertrophy (RVH).Measurements and Main Results: Antenatal PHi therapy preserves lung alveolar and vascular growth and lung function and prevents RVH after intrauterine ETX exposure. Antenatal administration of PHi markedly upregulates lung HIF-1a, HIF-2a, VEGF, and eNOS expression after ETX exposure.Conclusions: HIF augmentation improves lung structure and function, prevents RVH, and improves placental structure following antenatal ETX exposure. We speculate that antenatal or postnatal PHi therapy may provide novel strategies to prevent BPD due to antenatal inflammation.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

